Remove 2040 Remove Compliance Remove Conditions
article thumbnail

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update

Cannabis Law Report

” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. We recently announced a key milestone with the issuance of a method of use patent for ANEB-001, providing protection through 2040. Chief Executive Officer of Anebulo. “We

article thumbnail

Euro & UK Roundup: Czech Republic, Ireland, San Marino, UK

Cannabis Law Report

Legislation passed last July allows a Consultant doctor to prescribe medicinal cannabis, but it is restricted to just three conditions. A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain.